Literature DB >> 17690142

Compartmentalized NMDA receptor signalling to survival and death.

Francesc X Soriano1, Giles E Hardingham.   

Abstract

The ability of Ca(2+) influx through the N-methyl d-aspartate subclass of glutamate receptor (NMDA receptor) to both kill neurons and to promote survival under different circumstances is well established. Here we discuss the signal pathways that mediate this dichotomous signalling, and the factors that influence whether an NMDA receptor-dependent Ca(2+) signal results in a net pro-survival or pro-death effect. The magnitude of NMDA receptor activation, be it intensity or duration, is of course very important in determining the nature of the response to an episode of NMDA receptor activity, with excitotoxic death pathways requiring higher levels than survival pathways. However, the NMDA receptor is not merely a conduit for Ca(2+) influx: the consequences of NMDA receptor activity can be influenced by signalling molecules that physically associate with the NMDA receptor or indeed the location (synaptic versus extrasynaptic) of the receptor. Furthermore, we discuss the possibility that the Ca(2+) effectors of survival and death are in different subcellular locations, and thus depend on the spatial characteristics of the Ca(2+) transient. A greater understanding of these issues may point to ways of selectively blocking pro-death signalling in neurological disorders such as stroke, where global NMDA receptor antagonists have proved ineffective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690142      PMCID: PMC2277150          DOI: 10.1113/jphysiol.2007.138875

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  64 in total

1.  Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels.

Authors:  G E Hardingham; S Chawla; F H Cruzalegui; H Bading
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

2.  Neuronal death enhanced by N-methyl-D-aspartate antagonists.

Authors:  C Ikonomidou; V Stefovska; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

4.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

5.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression.

Authors:  G E Hardingham; S Chawla; C M Johnson; H Bading
Journal:  Nature       Date:  1997-01-16       Impact factor: 49.962

Review 6.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

7.  Autolysis parallels activation of mu-calpain.

Authors:  A Baki; P Tompa; A Alexa; O Molnár; P Friedrich
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

9.  Akt mediates the anti-apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells.

Authors:  Mireille Lafon-Cazal; Virgili Perez; Joël Bockaert; Philippe Marin
Journal:  Eur J Neurosci       Date:  2002-08       Impact factor: 3.386

10.  Imaging the spatial dynamics of calmodulin activation during mitosis.

Authors:  K Török; M Wilding; L Groigno; R Patel; M Whitaker
Journal:  Curr Biol       Date:  1998-06-04       Impact factor: 10.834

View more
  30 in total

1.  Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.

Authors:  F Suárez; Q Zhao; D T Monaghan; D E Jane; S Jones; A J Gibb
Journal:  Eur J Neurosci       Date:  2010-07-06       Impact factor: 3.386

Review 2.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

3.  Compartmentalized signalling in neurons.

Authors:  Paola Pedarzani; Shamshad Cockcroft; R A John Challiss
Journal:  J Physiol       Date:  2007-10-15       Impact factor: 5.182

4.  NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury.

Authors:  Denise R Cook; Amy J Gleichman; Stephanie A Cross; Shachee Doshi; Wenzhe Ho; Kelly L Jordan-Sciutto; David R Lynch; Dennis L Kolson
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

5.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.

Authors:  M Banasr; G M I Chowdhury; R Terwilliger; S S Newton; R S Duman; K L Behar; G Sanacora
Journal:  Mol Psychiatry       Date:  2008-09-30       Impact factor: 15.992

6.  Excitotoxic insults lead to peroxiredoxin hyperoxidation.

Authors:  Frédéric Léveillé; Francesc X Soriano; Sofia Papadia; Giles E Hardingham
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

7.  Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.

Authors:  Jian Xu; Pradeep Kurup; Yongfang Zhang; Susan M Goebel-Goody; Peter H Wu; Ammar H Hawasli; Matthew L Baum; James A Bibb; Paul J Lombroso
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

8.  Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro.

Authors:  Robert M Mitchell; Edward J Neafsey; Michael A Collins
Journal:  J Neurochem       Date:  2009-08-19       Impact factor: 5.372

9.  Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.

Authors:  Sylvia Fitting; Bogna M Ignatowska-Jankowska; Cecilia Bull; Robert P Skoff; Aron H Lichtman; Laura E Wise; Michael A Fox; Jianmin Su; Alexandre E Medina; Thomas E Krahe; Pamela E Knapp; William Guido; Kurt F Hauser
Journal:  Biol Psychiatry       Date:  2012-12-04       Impact factor: 13.382

10.  P38 MAPK inhibition protects against glutamate neurotoxicity and modifies NMDA and AMPA receptor subunit expression.

Authors:  Martha Catalina Rivera-Cervantes; Rolando Castañeda-Arellano; Ruben Darío Castro-Torres; Graciela Gudiño-Cabrera; Alfredo I Feria y Velasco; Antoni Camins; Carlos Beas-Zárate
Journal:  J Mol Neurosci       Date:  2014-08-30       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.